Xiaolu Yang

513 total citations
27 papers, 405 citations indexed

About

Xiaolu Yang is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Xiaolu Yang has authored 27 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Ophthalmology, 7 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Xiaolu Yang's work include Retinal Diseases and Treatments (7 papers), Glaucoma and retinal disorders (5 papers) and Ocular Oncology and Treatments (5 papers). Xiaolu Yang is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Glaucoma and retinal disorders (5 papers) and Ocular Oncology and Treatments (5 papers). Xiaolu Yang collaborates with scholars based in China, United States and Thailand. Xiaolu Yang's co-authors include Xun Xu, Huiyi Jin, Qing Gu, Dandan Zhang, Kun Liu, Arman Mashayekhi, Kun Liu, Lauren A. Dalvin, Bingshun Wang and Yi Xu and has published in prestigious journals such as PLoS ONE, Scientific Reports and FEBS Letters.

In The Last Decade

Xiaolu Yang

27 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolu Yang China 12 196 115 106 57 53 27 405
Kaiser Alam Saudi Arabia 16 225 1.1× 253 2.2× 86 0.8× 138 2.4× 26 0.5× 26 594
Tomohito Sato Japan 14 366 1.9× 137 1.2× 174 1.6× 64 1.1× 19 0.4× 47 551
Wei Tan China 14 211 1.1× 255 2.2× 134 1.3× 52 0.9× 11 0.2× 32 608
Jasmina Djordjević-Jocić Serbia 8 269 1.4× 96 0.8× 83 0.8× 30 0.5× 13 0.2× 20 392
Yuko Takemoto Japan 11 257 1.3× 58 0.5× 43 0.4× 45 0.8× 30 0.6× 14 414
Hirokuni Kitamei Japan 13 314 1.6× 64 0.6× 91 0.9× 46 0.8× 28 0.5× 19 448
Lingling Liang China 10 52 0.3× 118 1.0× 51 0.5× 21 0.4× 14 0.3× 41 294
Xintong Jiang China 12 195 1.0× 102 0.9× 180 1.7× 66 1.2× 41 0.8× 31 412
Peyton Morss United States 10 178 0.9× 176 1.5× 86 0.8× 39 0.7× 5 0.1× 17 406
Mineo Ozaki Japan 12 314 1.6× 149 1.3× 198 1.9× 9 0.2× 14 0.3× 30 438

Countries citing papers authored by Xiaolu Yang

Since Specialization
Citations

This map shows the geographic impact of Xiaolu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolu Yang more than expected).

Fields of papers citing papers by Xiaolu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolu Yang. The network helps show where Xiaolu Yang may publish in the future.

Co-authorship network of co-authors of Xiaolu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolu Yang. A scholar is included among the top collaborators of Xiaolu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolu Yang. Xiaolu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lü, Yi, et al.. (2023). A novel peptide derived from the mannose binding lectin inhibits LPS‐activated TLR4/NF‐κB signaling and suppresses ocular inflammation. Cell Biology International. 47(9). 1614–1626. 2 indexed citations
3.
Yang, Xiaolu, et al.. (2022). Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study. Radiation Oncology. 17(1). 208–208. 3 indexed citations
4.
Li, Liang, et al.. (2021). Application of different imaging methods for the localization of cerebrospinal fluid rhinorrhea: a comparative study. Annals of Palliative Medicine. 10(8). 8797–8807. 2 indexed citations
5.
Chang, Michael, Lauren A. Dalvin, Mehdi Mazloumi, et al.. (2020). Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age. Asia-Pacific Journal of Ophthalmology. 9(1). 29–38. 12 indexed citations
6.
Yang, Xiaolu, Lauren A. Dalvin, Mehdi Mazloumi, et al.. (2020). Impact of uveal melanoma thickness on post‐plaque radiotherapy outcomes in the prophylactic anti‐vascular endothelial growth factor era in 1131 patients. Clinical and Experimental Ophthalmology. 48(5). 610–623. 5 indexed citations
7.
Yang, Xiaolu, Lauren A. Dalvin, Mehdi Mazloumi, et al.. (2020). SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES. Retina. 41(2). 249–258. 20 indexed citations
8.
Lu, Cheng, Hanying Wang, Shaopin Zhu, et al.. (2019). KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis. Journal of Neuroinflammation. 16(1). 278–278. 17 indexed citations
9.
Shields, Carol L., Lauren A. Dalvin, Michael Chang, et al.. (2019). Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma. JAMA Ophthalmology. 138(2). 136–136. 44 indexed citations
10.
Zhu, Shaopin, et al.. (2018). PAPep Inhibits Secretion of Poly(I:C)-Induced Inflammatory Cytokines and ICAM-1 Expression in Corneal Fibroblasts by Suppressing the NF-κB/p38 Pathway. Journal of Ocular Pharmacology and Therapeutics. 34(5). 395–402. 2 indexed citations
11.
Zhang, Zhihua, Xiaolu Yang, Huiyi Jin, et al.. (2016). Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases. Scientific Reports. 6(1). 38326–38326. 12 indexed citations
12.
13.
Xu, Yan, Huiyi Jin, Xiaolu Yang, et al.. (2014). MicroRNA‐93 inhibits inflammatory cytokine production in LPS‐stimulated murine macrophages by targeting IRAK4. FEBS Letters. 588(9). 1692–1698. 46 indexed citations
14.
Tan, Xi, et al.. (2014). Ethyl Acetate Extract of Artemisia anomala S. Moore Displays Potent Anti‐Inflammatory Effect. Evidence-based Complementary and Alternative Medicine. 2014(1). 15 indexed citations
15.
Yang, Xiaolu, Haidong Zou, & Xun Xu. (2013). [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].. PubMed. 49(12). 1081–8. 3 indexed citations
16.
17.
Sun, Qiao, Tao Sun, Yi Xu, et al.. (2012). Primary Vitrectomy Versus Scleral Buckling for the Treatment of Rhegmatogenous Retinal Detachment: A Meta-Analysis of Randomized Controlled Clinical Trials. Current Eye Research. 37(6). 492–499. 64 indexed citations
18.
Yang, Xiaolu, Huiyi Jin, Kun Liu, Qing Gu, & Xun Xu. (2011). A Novel Peptide Derived from Human Pancreatitis-Associated Protein Inhibits Inflammation In Vivo and In Vitro and Blocks NF-Kappa B Signaling Pathway. PLoS ONE. 6(12). e29155–e29155. 25 indexed citations
19.
Jin, Huiyi, Xiaolu Yang, Kun Liu, Qing Gu, & Xun Xu. (2011). Effects of a novel peptide derived from human thrombomodulin on endotoxin-induced uveitis in vitro and in vivo. FEBS Letters. 585(21). 3457–3464. 11 indexed citations
20.
Yang, Xiaolu, Kun Liu, & Xun Xu. (2009). Update on treatments of diabetic macular edema. Chinese Medical Journal. 122(22). 2784–2790. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaiser Alam Breakdown of academic impact, for papers by Tomohito Sato Breakdown of academic impact, for papers by Wei Tan Breakdown of academic impact, for papers by Jasmina Djordjević-Jocić Breakdown of academic impact, for papers by Yuko Takemoto Breakdown of academic impact, for papers by Hirokuni Kitamei Breakdown of academic impact, for papers by Lingling Liang Breakdown of academic impact, for papers by Xintong Jiang Breakdown of academic impact, for papers by Peyton Morss Breakdown of academic impact, for papers by Mineo Ozaki
Rankless by CCL
2026